$JNJ
AI AnalysisGenerated on May 11, 2026
AI Score
Hold$JNJ
Johnson & Johnson
$JNJNYSEHealthcareMega-Cap
J&J is a diversified healthcare company with businesses in pharmaceuticals (Innovative Medicine) and medical devices (MedTech).
Market Cap
$360.0B
Revenue (TTM)
$85.2B
+5.0%
Net Income (TTM)
$14.3B
+8.0%
EPS (TTM)
$5.90
P/E Ratio
16.5
Dividend Yield
3.0%
52-Week Range
$140-$168
Beta
0.52
Dimension Scores
Fundamental
73Technical
62Sentiment
68Risk / Reward
78Momentum
58Financial Health
Profitability
78strong
Growth
61moderate
Liquidity
86strong
Solvency
75strong
Efficiency
71strong
Valuation, technical analysis, investment thesis, risk assessment and more for $JNJ
Free · No credit card required
Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.